Biomarkers for Alzheimer's Disease in Saliva: A Systematic Review
- PMID: 31191751
- PMCID: PMC6525835
- DOI: 10.1155/2019/4761054
Biomarkers for Alzheimer's Disease in Saliva: A Systematic Review
Abstract
Background: The histopathological changes of Alzheimer's disease (AD) are detectable decades prior to its clinical expression. However, there is a need for an early, inexpensive, noninvasive diagnostic biomarker to detect specific Alzheimer pathology. Recently developed neuroimaging biomarkers show promising results, but these methods are expensive and cause radiation. Furthermore, the analysis of cerebrospinal fluid (CSF) biomarkers requires an invasive lumbar puncture. Saliva is an easily obtained body fluid, and a stable saliva biomarker would therefore be a promising candidate for a future method for diagnosing AD. The purpose of this systematic review was to investigate studies of biomarkers in saliva samples for the diagnosis of AD.
Methods: The included articles were identified through a literature search in PubMed and Google Scholar for all articles until November 1st, 2018, and furthermore, all reference lists of included articles were reviewed by hand. We included articles written in English investigating saliva from patients with AD and a control group.
Results: A total of 65 studies were identified, whereof 16 studies met the inclusion criteria and were included in the systematic review. A plethora of different biomarkers were investigated, and ten out of the sixteen studies showed a statistical significance in biomarkers between patients with AD and healthy, elderly controls, among these biomarkers for specific AD pathology (amyloid beta 1-42 (Aβ42) and tau).
Conclusion: Aβ42 and tau seem to be worthy candidates for future salivary biomarkers for AD, but other biomarkers such as lactoferrin and selected metabolites also have potential. More studies must be carried out with larger sample sizes and a standardization of the sampling and processing method. Factors such as diurnal variation, AD patients' decreased ability of oral self-care, and salivary flowrates must be taken into consideration.
Figures
Similar articles
-
A Systematic Review on the Feasibility of Salivary Biomarkers for Alzheimer's Disease.J Prev Alzheimers Dis. 2021;8(1):84-91. doi: 10.14283/jpad.2020.57. J Prev Alzheimers Dis. 2021. PMID: 33336229
-
An Update of Salivary Biomarkers for the Diagnosis of Alzheimer's Disease.Int J Mol Sci. 2025 Feb 26;26(5):2059. doi: 10.3390/ijms26052059. Int J Mol Sci. 2025. PMID: 40076682 Free PMC article. Review.
-
Lactoferrin in cerebrospinal fluid and saliva is not a diagnostic biomarker for Alzheimer's disease in a mixed memory clinic population.EBioMedicine. 2021 May;67:103361. doi: 10.1016/j.ebiom.2021.103361. Epub 2021 May 8. EBioMedicine. 2021. PMID: 33975253 Free PMC article.
-
Aβ42 as a Biomarker of Alzheimer's Disease: Is Saliva a Viable Alternative to Cerebrospinal Fluid?Brain Sci. 2022 Dec 17;12(12):1729. doi: 10.3390/brainsci12121729. Brain Sci. 2022. PMID: 36552188 Free PMC article.
-
Core candidate neurochemical and imaging biomarkers of Alzheimer's disease.Alzheimers Dement. 2008 Jan;4(1):38-48. doi: 10.1016/j.jalz.2007.08.006. Epub 2007 Dec 21. Alzheimers Dement. 2008. PMID: 18631949 Review.
Cited by
-
Recent advances in pre-clinical diagnosis of Alzheimer's disease.Metab Brain Dis. 2022 Aug;37(6):1703-1725. doi: 10.1007/s11011-021-00733-4. Epub 2021 Apr 26. Metab Brain Dis. 2022. PMID: 33900524 Review.
-
Altered Mitochondrial Morphology and Bioenergetics in a New Yeast Model Expressing Aβ42.Int J Mol Sci. 2023 Jan 4;24(2):900. doi: 10.3390/ijms24020900. Int J Mol Sci. 2023. PMID: 36674415 Free PMC article.
-
Is liquid biopsy mature enough for the diagnosis of Alzheimer's disease?Front Aging Neurosci. 2022 Aug 5;14:977999. doi: 10.3389/fnagi.2022.977999. eCollection 2022. Front Aging Neurosci. 2022. PMID: 35992602 Free PMC article. Review.
-
APOE Variants in an Iberian Alzheimer Cohort Detected through an Optimized Sanger Sequencing Protocol.Genes (Basel). 2020 Dec 22;12(1):4. doi: 10.3390/genes12010004. Genes (Basel). 2020. PMID: 33375167 Free PMC article.
-
Potential non-invasive biomarkers of chronic sleep disorders identified by salivary metabolomic profiling among middle-aged Japanese men.Sci Rep. 2025 Apr 21;15(1):10980. doi: 10.1038/s41598-025-95403-1. Sci Rep. 2025. PMID: 40258870 Free PMC article.
References
-
- Martin Prince A. World Alzheimer Report 2015: the global impact of dementia: an analysis of prevalence, incidence, cost and trends. Alzheimer's Disease International; 2015.
-
- What is Alzheimer’s | Alzheimer’s Association. November 2018, https://www.alz.org/alzheimers-dementia/what-is-alzheimers.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous